Literature DB >> 12223533

Cellular regulation of RGS proteins: modulators and integrators of G protein signaling.

Susanne Hollinger1, John R Hepler.   

Abstract

Regulators of G protein signaling (RGS) and RGS-like proteins are a family (>30 members) of highly diverse, multifunctional signaling proteins that bind directly to activated G alpha subunits. Family members are defined by a shared RGS domain, which is responsible for G alpha binding and markedly stimulates the GTPase activity of G alpha subunits leading to their deactivation and termination of downstream signals. Although much has been learned in recent years about the biochemistry of RGS/G alpha interactions, considerably less is known about the broader cellular roles and regulation of RGS proteins. Recent findings indicate that cellular mechanisms such as covalent modification, alternative gene splicing, and protein processing can dictate the activity and subcellular localization of RGS proteins. Many family members also directly link G proteins to a growing list of signaling proteins with diverse cellular roles. New findings indicate that RGS proteins act not as dedicated inhibitors but, rather, as tightly regulated modulators and integrators of G protein signaling. In some cases, RGS proteins modulate the lifetime and kinetics of both slow-acting (e.g., Ca(2+) oscillations) and fast-acting (e.g., ion conductances, phototransduction) signaling responses. In other cases, RGS proteins integrate G proteins with signaling pathways linked to such diverse cellular responses as cell growth and differentiation, cell motility, and intracellular trafficking. These and other recent studies with animal model systems indicate that RGS proteins play important roles in both physiology and disease. Recognition of the central functions these proteins play in vital cellular processes has focused our attention on RGS proteins as exciting new candidates for therapeutic intervention and drug development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223533     DOI: 10.1124/pr.54.3.527

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  273 in total

1.  Regulator of G protein signaling 14 (RGS14) is expressed pre- and postsynaptically in neurons of hippocampus, basal ganglia, and amygdala of monkey and human brain.

Authors:  Katherine E Squires; Kyle J Gerber; Jean-Francois Pare; Mary Rose Branch; Yoland Smith; John R Hepler
Journal:  Brain Struct Funct       Date:  2017-08-03       Impact factor: 3.270

2.  Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Wen-Lin Cheng; Pi-Xiao Wang; Tao Wang; Yan Zhang; Cheng Du; Hongliang Li; Yong Ji
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

3.  Allosteric inhibition of the regulator of G protein signaling-Galpha protein-protein interaction by CCG-4986.

Authors:  David L Roman; Levi L Blazer; C Aaron Monroy; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2010-06-07       Impact factor: 4.436

4.  RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.

Authors:  Jeffery N Talbot; Emily M Jutkiewicz; Steven M Graves; Crystal F Clemans; Melanie R Nicol; Richard M Mortensen; Xinyan Huang; Richard R Neubig; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

5.  Novel role of RGS2 in regulation of antioxidant homeostasis in neuronal cells.

Authors:  Samina Salim; Mohammad Asghar; Manish Taneja; Iiris Hovatta; Yuh-Lin Wu; Kaustuv Saha; Nada Sarraj; Brian Hite
Journal:  FEBS Lett       Date:  2011-04-16       Impact factor: 4.124

6.  Type 5 G protein beta subunit (Gbeta5) controls the interaction of regulator of G protein signaling 9 (RGS9) with membrane anchors.

Authors:  Ikuo Masuho; Hideko Wakasugi-Masuho; Ekaterina N Posokhova; Joseph R Patton; Kirill A Martemyanov
Journal:  J Biol Chem       Date:  2011-04-21       Impact factor: 5.157

7.  Characterization of the GRK2 binding site of Galphaq.

Authors:  Peter W Day; John J G Tesmer; Rachel Sterne-Marr; Leslie C Freeman; Jeffrey L Benovic; Philip B Wedegaertner
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

8.  Differential effects of the Gβ5-RGS7 complex on muscarinic M3 receptor-induced Ca2+ influx and release.

Authors:  Darla Karpinsky-Semper; Claude-Henry Volmar; Shaun P Brothers; Vladlen Z Slepak
Journal:  Mol Pharmacol       Date:  2014-02-28       Impact factor: 4.436

9.  Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG.

Authors:  Ancy D Nalli; Divya P Kumar; Othman Al-Shboul; Sunila Mahavadi; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

10.  Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.

Authors:  G Rivero; A M Gabilondo; J A García-Sevilla; L F Callado; R La Harpe; B Morentin; J J Meana
Journal:  Psychopharmacology (Berl)       Date:  2012-10-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.